Cholinergic basal forebrain degeneration due to sleep-disordered breathing exacerbates pathology in a mouse model of Alzheimer’s disease

• Published in: Nature communications 2022-11, Vol.13 (1), p.6543-6543, Article 6543
• Main Authors: Qian, Lei, Rawashdeh, Oliver, Kasas, Leda, Milne, Michael R., Garner, Nicholas, Sankorrakul, Kornraviya, Marks, Nicola, Dean, Matthew W., Kim, Pu Reum, Sharma, Aanchal, Bellingham, Mark C., Coulson, Elizabeth J.
• Format: Article
• Language: English
• Subjects: 631/378; 631/378/1689; 631/378/1689/1283; 631/443/376; 64/110; 64/60; 82/51; 9/26; 96/63; Alzheimer Disease - pathology; Alzheimer's disease; Animals; Apnea; Basal forebrain; Basal Forebrain - pathology; Cholinergic Agents; Cholinergics; Cognitive ability; Degeneration; Disease Models, Animal; Disruption; Epidemiology; Forebrain; Humanities and Social Sciences; Humans; Hypoxemia; Hypoxia; Hypoxia - pathology; Impairment; Inflammation; Mice; multidisciplinary; Neurodegeneration; Neurodegenerative diseases; Phenotypes; Risk analysis; Risk factors; Science; Science (multidisciplinary); Sleep Apnea Syndromes - complications; Sleep disorders; Tegmentum
• ISSN: 2041-1723; 2041-1723
• DOI: 10.1038/s41467-022-33624-y

Although epidemiological studies indicate that sleep-disordered breathing (SDB) such as obstructive sleep apnea is a strong risk factor for the development of Alzheimer’s disease (AD), the mechanisms of the risk remain unclear. Here we developed a method of modeling SDB in mice that replicates key features of the human condition: altered breathing during sleep, sleep disruption, moderate hypoxemia, and cognitive impairment. When we induced SDB in a familial AD model, the mice displayed exacerbation of cognitive impairment and the pathological features of AD, including increased levels of amyloid-beta and inflammatory markers, as well as selective degeneration of cholinergic basal forebrain neurons. These pathological features were not induced by chronic hypoxia or sleep disruption alone. Our results also revealed that the cholinergic neurodegeneration was mediated by the accumulation of nuclear hypoxia inducible factor 1 alpha. Furthermore, restoring blood oxygen levels during sleep to prevent hypoxia prevented the pathological changes induced by the SDB. These findings suggest a signaling mechanism whereby SDB induces cholinergic basal forebrain degeneration. Sleep-disordered breathing is a risk factor for Alzheimer’s disease. Here the authors use mesopontine tegmentum lesion to model sleep disordered breathing in a mouse model of Alzheimer’s disease, and find that some features of the Alzheimer’s disease-like phenotype are exacerbated.